BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38460245)

  • 1. miRNAs Role in Wilms tumor pathogenesis: Signaling pathways interplay.
    Alfaifi J
    Pathol Res Pract; 2024 Apr; 256():155254. PubMed ID: 38460245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of microRNAs in Wilms' tumors.
    Yu X; Li Z; Chan MT; Wu WK
    Tumour Biol; 2016 Feb; 37(2):1445-50. PubMed ID: 26634744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
    Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
    BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
    Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
    Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
    Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-140-5p and miR-92a-3p suppress the cell proliferation, migration and invasion and promoted apoptosis in Wilms' tumor by targeting FRS2.
    Li JL; Luo P
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):97-108. PubMed ID: 31957822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The yin and yang of kidney development and Wilms' tumors.
    Hohenstein P; Pritchard-Jones K; Charlton J
    Genes Dev; 2015 Mar; 29(5):467-82. PubMed ID: 25737276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway.
    Liu GL; Yang HJ; Liu B; Liu T
    J Cell Biochem; 2017 Oct; 118(10):3424-3434. PubMed ID: 28322459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes.
    Ludwig N; Werner TV; Backes C; Trampert P; Gessler M; Keller A; Lenhof HP; Graf N; Meese E
    Int J Mol Sci; 2016 Mar; 17(4):475. PubMed ID: 27043538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of Bcl-2 in Wilms' tumor and oncogenic potential of Bcl-X(L) in rare tumor cases.
    Re GG; Hazen-Martin DJ; El Bahtimi R; Brownlee NA; Willingham MC; Garvin AJ
    Int J Cancer; 1999 Apr; 84(2):192-200. PubMed ID: 10096254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic Wilms' tumor: clinical and pathologic studies.
    Bonadio JF; Storer B; Norkool P; Farewell VT; Beckwith JB; D'Angio GJ
    J Clin Oncol; 1985 Apr; 3(4):513-20. PubMed ID: 2984344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual association of Wilms' tumor with cystic diseases of kidney: A pathologic surprise.
    Osama M; Nangia A; Chatterjee P; Shah SS; Suman S; Sarin YK
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
    Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
    Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in the pathogenesis of cystic kidney disease.
    Phua YL; Ho J
    Curr Opin Pediatr; 2015 Apr; 27(2):219-26. PubMed ID: 25490692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaplastic histology Wilms' tumors registered to the Japan Wilms' Tumor Study Group are less aggressive than that in the National Wilms' Tumor Study 5.
    Oue T; Koshinaga T; Takimoto T; Okita H; Tanaka Y; Nozaki M; Haruta M; Kaneko Y; Fukuzawa M;
    Pediatr Surg Int; 2016 Sep; 32(9):851-5. PubMed ID: 27473009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-483-3p Promotes Proliferation, Migration, and Invasion and Induces Chemoresistance of Wilms' Tumor Cells.
    Che G; Gao H; Tian J; Hu Q; Xie H; Zhang Y
    Pediatr Dev Pathol; 2020; 23(2):144-151. PubMed ID: 31498707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor.
    Re GG; Willingham MC; el Bahtimi R; Brownlee NA; Hazen-Martin DJ; Garvin AJ
    Mod Pathol; 1997 Feb; 10(2):129-36. PubMed ID: 9127318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms' tumor and other renal tumors of childhood: a selective review from the National Wilms' Tumor Study Pathology Center.
    Beckwith JB
    Hum Pathol; 1983 Jun; 14(6):481-92. PubMed ID: 6303938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hyperthermia 42.5 degrees C/120 min on 3H-thymidine incorporation in different tissue components of Wilms' tumors: an in vitro study.
    Willnow U; Dumon K; Godehardt E
    Klin Padiatr; 1996; 208(4):145-50. PubMed ID: 8776702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CCT4/ErbB signaling in nephroblastoma: Implications for a biomarker of Wilms tumor.
    Wang H; Zhang L; Liu B; Su J; Ni X
    Medicine (Baltimore); 2023 Apr; 102(15):e33219. PubMed ID: 37058032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.